AtriCure (ATRC) Cash from Investing Activities (2010 - 2026)

AtriCure (ATRC) has reported Cash from Investing Activities for 17 consecutive years, with -$3.8 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash from Investing Activities rose 50.85% year-over-year to -$3.8 million; the TTM figure through Jun 2026 stood at -$12.8 million (up 34.71% YoY), while the FY2025 annual figure was -$14.6 million, down 148.12% from the prior year.
• Cash from Investing Activities grew to -$3.8 million in Q2 2026 per ATRC's latest filing, from -$3.9 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $30.9 million in Q2 2024 and bottomed at -$16.1 million in Q2 2023.
• Historically, Cash from Investing Activities has averaged $4.1 million across 5 years, with a median of -$2.1 million in 2025.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities soared 550.14% — and 2024, when it plunged 427.39%.
• AtriCure's Cash from Investing Activities stood at $7.0 million in 2022, then tumbled by 139.79% to -$2.8 million in 2023, then slumped by 427.39% to -$14.7 million in 2024, then jumped by 82.29% to -$2.6 million in 2025, then plunged by 44.73% to -$3.8 million in 2026.
• Business Quant data shows ATRC's Cash from Investing Activities at -$3.8 million in Q2 2026, -$3.9 million in Q1 2026, and -$2.6 million in Q4 2025.